20
Views
16
CrossRef citations to date
0
Altmetric
Original Article

A Double-Blind, Placebo-Controlled, Crossover, Study to Evaluate the Efficacy of Subcutaneous Sumatriptan in the Treatment of Atypical Facial Pain

, &
Pages 301-309 | Received 05 Apr 1996, Published online: 07 Jul 2009

References

  • Connor H. E., Feniuk W., Humphrey P. P. A. Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. British Journal of Pharmacology 1989; 96: 379–87
  • Davis L., Pollock L. J. The role of the sympathetic nervous system in the production of pain in the head. Archives of Neurology and Psychiatry 1932; 27: 282–93
  • Derbyshire S. W. G., Jones A. K. P., Devani P., Friston K. J., Feinmann C., Harris M., Pearce S., Watson J. D. G., Frackowiak R. S. J. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. Journal of Neurology, Neurosurgery and Psychiatry 1994; 571: 1166–72
  • Donoghue S., Durham J. M., Yates S. A., Endersby C. A double-blind study to compare the efficacy of subcutaneous GR43175C with that of subcutaneous placebo injection in the acute treatment of migraine. 1989, Glaxo Group Research Report Number GCV/89/006
  • Drummond P. D. Vascular changes in atypical facial pain. Headache 1988; 28: 121–3
  • Edvinsson L., Jansen I. Characterization of 5-HT receptors mediating contraction of human cerebral, meningial and temporal arteries: target for GR43175 in acute treatment of migraine. Cephallagia 1989; 9: 39–40, (suppl 10)
  • Engel G. L. Psychogenic pain and the pain prone patient. American Journal of Medicine 1959; 196: 129–36
  • Evans F. J. The placebo response in pain control. Psychopharmacology Bulletin 1981; 17: 72–6
  • Feinmann C., Harris M. Psychogenic facial pain, Part I: the clinical presentation. British Dental Journal 1984; 156: 165–8
  • Feinmann C., Harris M., Cawley R. Psychogenic facial pain: presentation and treatment. British Medical Journal, 288: 436–8
  • Feniuk W., Humphrey P. P. A., Perrer M. J. The selective carotid vasoconstrictor actions of GR43175 in anaesthetized dogs. British Journal of Pharmacology 1989; 96: 83–90
  • Frazier C. H., Russell E. C. Neuralgia of the face. An analysis of 754 cases with relation to pain and other sensory phenomena before and after operation. Archives of Neurology and Psychiatry 1924; 11: 557–63
  • Gabriel M., Orona E., Foster K., Lambert R. W. Mechanisms and generality of stimulus significance coding in a mammalian model system. Advances in Behavioral Biology 1982; 26: 535–67
  • Humphrey P. P. A., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates I. H., Butina D. GR43175 a selective agonist for the 5-HT, -like receptor in the dog isolated saphenous vein. British Journal of Pharmacology 1988; 94: 1123–32
  • Hunter S. Atypical facial pain–rewarding to treat. The Practitioner 1994; 238: 186–193
  • Koch G. G. The use of non-parametric methods in the statistical analysis of the two-period changeover design. Applied Statistics 1972; 36: 192–204
  • Kuhn R. The treatment of depression state with imipramine hydrochloride. American Journal of Psychiatry 1958; 115: 459–64
  • Lacelles R. G. Atypical facial pain and depression. British Journal of Psychiatry 1966; 112: 651–59
  • Lesse S. Atypical facial pain syndrome of psychogenic origin. Journal of Nervous and Mental Diseases 1956; 124: 341–6
  • McCarthy B. G., Peroutka S. J. Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR43175). Headache 1989; 29: 420–2
  • Melzack R. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191–7
  • Moore D. S., Nally F. F. Atypical facial pain. An analysis of 100 patients with discussion. Journal of Canadian Dental Association 1975; 7: 396–401
  • Moskowitz M. A. Neurogenic venus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends in Pharmacological Sciences 1992; 13: 307–11
  • Pardo J. V., Pardo P. J., Janer K. W., Raichle M. E. The anterior arigulate cortex mediates processing selection in the stroop attentional conflict paradigm. Neurobiology 1990; 87: 256–9
  • Peroutka S. J., McCarthy B. G. Sumatriptan (GR43175) interacts selectively with 5-HT IB and 5-HT ID binding sites. European Journal of Pharmacology 1989; 163: 133–6
  • Peroutka S. J., Switzer J. A., Hanik A. Identification of 5-hydroxytryptamine 1 D binding sites in human brain membrane. Synapse 1989; 3: 61–6
  • Pozos A., Probot A., Palacio J. M. Serotonin receptors in the human brain: III Autoradiagraphic mapping of serotonin-1 receptors. Neuroscience 1987; 21: 97–122
  • Reik L. R., Jr. Atypical facial pain. A reappraisal. Headache 1985; 25: 30–2
  • Remick R. H., Blasberg B., Barton J. S., Campos P. E., Miles J. E. Ineffective dental and surgical treatment association with atypical facial pain. Oral Surgery 1983; 55: 355–8
  • Remick R. H., Blasberg B. Psychogenic aspect of atypical facial pain. Canadian Dental Association 1985; 51: 913–15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.